/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.
Curis, Inc. (NASDAQ:CRIS – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 2,350,000 shares, a drop of 6.0% from the February 28th total of 2,500,000 shares. Based on an average daily trading volume, of 540,700 shares, the days-to-cover ratio is […]
/PRNewswire/ The global phosphoinositide 3-kinase (PI3K) inhibitors market size is estimated to grow by USD 71.29 million from 2021 to 2026, according to.
Curis to Present at Upcoming Healthcare Conferences in April streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.